PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Unité des Virus Émergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France.\', \'Université de Paris, IAME, INSERM, Paris, France.\', \'Laboratoire Vet-Histo, Marseille, France.\', \'Laboratoire de Pharmacocinétique et Toxicologie, Hôpital La Timone, APHM, Marseille, France.\', \'Unité des Virus Émergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France. antoine.nougairede@univ-amu.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-021-21992-w
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 33741945
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all